All filters
Abstracts
A Novel Approach Continuum from Identification to Elimination in HCV-Infected Individuals on Opioid Substitution Therapy and High-Risk Populations
T. Stainbrook Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Risks factors associated with HIV and hepatitis C virus co-infection among people who inject drugs in Cambodia
C. Saing Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
A Model for Collaborative Care to Increase Testing and Treatment of HCV in a Shelter Population During COVID-19
N. Gale Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Concordance between FibroScan® and Aspartate aminotransferase-to-Platelet Ratio Index (APRI) using different cut-off values in 301 Asian adults with chronic HCV with no or compensated cirrhosis in Thailand and Malaysia
T. Soek-Siam Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Strategies for population-based screening and treatment of hepatitis B in sub-Saharan Africa: a mathematical modelling study in The Gambia
N. Schmit  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Sustained reduction in prevalence of Hepatitis C viremina in the prison setting after 3rd year of TraPHepC (Treatment as prevention for hepatitis C) program in Iceland
R. Fridriksdottir Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
The Effect of COVID-19 on the Hepatitis C Screening in Georgia
A. Aslanikashvili Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Reducing Read Time of Point of Care Test Preserves Detection of Hepatitis C Virus and Reduces Need for Reflex RNA
D. Smookler  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Frequency of Occult Hepatitis B Virus among blood Donors in Khartoum State, Sudan: a preliminary study.
M. Yassin Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
A novel point -of- care test (POC) for diagnosis of hepatitis Core antigen
G. Shiha  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Validation of a novel point-of-care ALT test to determine treatment eligibility in hepatitis B patients: a pilot cohort study
J. Howell Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Hepatitis C Epidemic and Barriers to Testing among MSM with High Risk Behaviors in China: A GSN-delivered Cross-sectional Study
Y. Tang Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Drug resistance of hepatitis C virus to NS5A protein inhibitors in Belarus
E. Gasich Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Seroprevalence of Hepatitis B and C Among HIV-infected Children and Adolescents Receiving Antiretroviral Therapy in Anambra State, Nigeria
S. Kalu  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Detection of Viral Hepatitis and Linking to the Health Care of Trans People - InCide Project Contributions
F. Frazão de Aguiar Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Expression of HBeAg, HBsAg, anti- HBe and anti-HCV in individuals with elevated IL-10
M. Olaniyan Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Prevalence of Hepatitis B among Prisoners at Winneba Male and Nsawam Female Prison in Ghana
T. Owusu-Ansah Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Immune Response to Hepatitis B Vaccine Following Complete Immunization of Children Attending Two Regional Hospitals in the Southwest Region of Cameroon: A Cross Sectional Study
E. Anutebeh Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Results from two phase-3 double-blind, randomized, controlled trials, PROTECT and CONSTANT, evaluating immunogenicity and safety of the 3-antigen hepatitis B vaccine, Sci-B-Vac®, compared to the single-antigen vaccine, Engerix ® in adults
F. Diaz-Mitoma Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Evaluation of hepatitis B vaccine efficacy among healthcare worker at Laquintinie Hospital, Douala, Cameroon.
R. Kamga Wouambo Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Results of A Hepatitis C (HCV) Re-Engagement Strategy For Vulnerable Populations
G. Macphail Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Hep Free 2030: Planning for Hepatitis Elimination in Hawai`i as Nimble, Collaborative Practice
T. Pham Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Ledipasvir 90 mg/ Sofosbuvir 400 mg for treatment of Chronic Hepatitis C genotype 4 adolescents: Towards elimination of hepatitis in children
R. Soliman Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Contact tracing to engage hard to reach injection networks and achieve micro-elimination: description of the ‘source patient indentification and group overlap treatment’ (spigot) pilot program
B. Eckhardt  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020